Aurinia Pharmaceuticals Inc (AUPH) with a beta value of 1.19 appears to be a promising investment opportunity.
A new trading day began on Monday, with Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stock price down -3.02% from the previous day of trading, before settling